[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

about

Discovering the meaning of monoclonal gammopathy of undetermined significance: current knowledge, future challenges.

P2860

Q38978902-B0FA1EE4-A90C-454B-9BAB-2E063689E28B

P2860

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

Item

http://www.wikidata.org/entity/Q43704889

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@en

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@nl

type

Item

label

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@en

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@nl

prefLabel

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@en

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@nl

P1476

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

@en

P2093

K Hübel

http://www.w3.org/2001/XMLSchema#string

M Hallek

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

P304

709-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00108-012-3215-2

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23670732

http://www.w3.org/2001/XMLSchema#string

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

about

P2860

P2860

[Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698